Additional file 1 of Tumor microenvironment-responsive spherical nucleic acid nanoparticles for enhanced chemo-immunotherapy

Abstract

Additional file 1: Table S1. The size, PDI and zeta potential of MCMD NPs in different solution. Figure S1. The size distribution of MCMD NPs in water. Figure S2. The expression levels of MHC-II on BMDCs treated with PBS, free MC and MC NPs were measured with flow cytometers. Data were expressed in the form of mean ± SD. * P<0.05, ****P<0.0001. Figure S3. The expression levels of CD80 on BMDCs treated with PBS, free MC and MC NPs were measured with flow cytometers. Data were expressed in the form of mean ± SD. ** P<0.01, ****P<0.0001. Figure S5. H&E staining results of tumor and heart tissues in different groups. Figure S6. Representative FACS plots and histogram of percentage of CD3+ CD4+ and CD3+CD8+ T cells in lymph nodes.